Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Nature ; 618(7964): 365-373, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37225978

ABSTRACT

Birth presents a metabolic challenge to cardiomyocytes as they reshape fuel preference from glucose to fatty acids for postnatal energy production1,2. This adaptation is triggered in part by post-partum environmental changes3, but the molecules orchestrating cardiomyocyte maturation remain unknown. Here we show that this transition is coordinated by maternally supplied γ-linolenic acid (GLA), an 18:3 omega-6 fatty acid enriched in the maternal milk. GLA binds and activates retinoid X receptors4 (RXRs), ligand-regulated transcription factors that are expressed in cardiomyocytes from embryonic stages. Multifaceted genome-wide analysis revealed that the lack of RXR in embryonic cardiomyocytes caused an aberrant chromatin landscape that prevented the induction of an RXR-dependent gene expression signature controlling mitochondrial fatty acid homeostasis. The ensuing defective metabolic transition featured blunted mitochondrial lipid-derived energy production and enhanced glucose consumption, leading to perinatal cardiac dysfunction and death. Finally, GLA supplementation induced RXR-dependent expression of the mitochondrial fatty acid homeostasis signature in cardiomyocytes, both in vitro and in vivo. Thus, our study identifies the GLA-RXR axis as a key transcriptional regulatory mechanism underlying the maternal control of perinatal cardiac metabolism.


Subject(s)
Fatty Acids , Glucose , Heart , Milk, Human , gamma-Linolenic Acid , Female , Humans , Infant, Newborn , Pregnancy , Chromatin/genetics , Fatty Acids/metabolism , gamma-Linolenic Acid/metabolism , gamma-Linolenic Acid/pharmacology , Gene Expression Regulation/drug effects , Glucose/metabolism , Heart/drug effects , Heart/embryology , Heart/growth & development , Homeostasis , In Vitro Techniques , Milk, Human/chemistry , Mitochondria/drug effects , Mitochondria/metabolism , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Retinoid X Receptors/metabolism , Transcription Factors/metabolism
3.
Nat Metab ; 2(9): 974-988, 2020 09.
Article in English | MEDLINE | ID: mdl-32943786

ABSTRACT

Proinflammatory macrophages are key in the development of obesity. In addition, reactive oxygen species (ROS), which activate the Fgr tyrosine kinase, also contribute to obesity. Here we show that ablation of Fgr impairs proinflammatory macrophage polarization while preventing high-fat diet (HFD)-induced obesity in mice. Systemic ablation of Fgr increases lipolysis and liver fatty acid oxidation, thereby avoiding steatosis. Knockout of Fgr in bone marrow (BM)-derived cells is sufficient to protect against insulin resistance and liver steatosis following HFD feeding, while the transfer of Fgr-expressing BM-derived cells reverts protection from HFD feeding in Fgr-deficient hosts. Scavenging of mitochondrial peroxides is sufficient to prevent Fgr activation in BM-derived cells and HFD-induced obesity. Moreover, Fgr expression is higher in proinflammatory macrophages and correlates with obesity traits in both mice and humans. Thus, our findings reveal the mitochondrial ROS-Fgr kinase as a key regulatory axis in proinflammatory adipose tissue macrophage activation, diet-induced obesity, insulin resistance and liver steatosis.


Subject(s)
Diet, High-Fat , Inflammation/physiopathology , Macrophage Activation , Obesity/enzymology , Obesity/physiopathology , Proto-Oncogene Proteins/metabolism , src-Family Kinases/metabolism , Adipose Tissue, White/metabolism , Animals , Bone Marrow Cells/metabolism , Fatty Liver/genetics , Fatty Liver/physiopathology , Insulin Resistance , Interleukin-1beta/biosynthesis , Magnetic Resonance Imaging , Mice, Inbred C57BL , Mice, Knockout , Mitochondria, Liver/metabolism , Obesity/genetics , Proto-Oncogene Proteins/genetics , Reactive Oxygen Species/metabolism , src-Family Kinases/genetics
4.
Sci Adv ; 6(31): eaba5345, 2020 07.
Article in English | MEDLINE | ID: mdl-32832682

ABSTRACT

Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues.

5.
Aging Cell ; 18(6): e13044, 2019 12.
Article in English | MEDLINE | ID: mdl-31560167

ABSTRACT

Neuronal activity regulates cognition and neural stem cell (NSC) function. The molecular pathways limiting neuronal activity during aging remain largely unknown. In this work, we show that p38MAPK activity increases in neurons with age. By using mice expressing p38α-lox and CamkII-Cre alleles (p38α∆-N), we demonstrate that genetic deletion of p38α in neurons suffices to reduce age-associated elevation of p38MAPK activity, neuronal loss and cognitive decline. Moreover, aged p38α∆-N mice present elevated numbers of NSCs in the hippocampus and the subventricular zone. These results reveal novel roles for neuronal p38MAPK in age-associated NSC exhaustion and cognitive decline.


Subject(s)
Aging/metabolism , Cognitive Dysfunction/metabolism , Mitogen-Activated Protein Kinase 14/metabolism , Neural Stem Cells/metabolism , Neurons/metabolism , Animals , Cognitive Dysfunction/pathology , Mice , Neural Stem Cells/pathology
6.
J Neurochem ; 112(6): 1574-83, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20067579

ABSTRACT

Phospholipases A(2) (PLA(2)) participate in neuronal death signalling pathways because of their ability to release lipid mediators, although the contribution of each isoform and mechanism of neurotoxicity are still elusive. Using a novel fluorogenic method to assess changes in a PLA(2) activity by flow cytometry, here we show that the group IIA secretory phospholipase A(2) isoform (GIIA) was specifically activated in cortical neurons following stimulation of N-methyl-d-aspartate glutamate receptor subtype (NMDAR). For activation, GIIA required Ca(2+) and reactive oxygen/nitrogen species, and inhibition of its activity fully prevented NMDAR-mediated neuronal apoptotic death. Superoxide, nitric oxide or peroxynitrite donors stimulated GIIA activity, which mediated neuronal death. Intriguingly, we also found that GIIA activity induced mitochondrial superoxide production after NMDAR stimulation. These results reveal a novel role for GIIA in excitotoxicity both as target and producer of superoxide in a positive-loop of activation that may contribute to the propagation of neurodegeneration.


Subject(s)
Apoptosis/physiology , Cerebral Cortex/cytology , Group II Phospholipases A2/metabolism , Neurons/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Annexin A5/metabolism , Apoptosis/drug effects , Calcium/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Flow Cytometry/methods , Glutamic Acid/pharmacology , Group II Phospholipases A2/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Neurons/drug effects , Nitric Oxide Donors/pharmacology , Nitroso Compounds/pharmacology , Pregnancy , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Xanthine/pharmacology , Xanthine Oxidase/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...